Is melatonin supplementation safe for patients with cardiac conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melatonin Safety in Cardiac Patients

Melatonin is safe for patients with cardiac conditions, including those undergoing cardiac surgery, with no documented cardiac complications and potential cardiovascular benefits. 1

Evidence Supporting Cardiovascular Safety

The most compelling evidence comes from perioperative cardiac surgery data, where melatonin has been extensively studied:

  • The Society for Perioperative Assessment and Quality Improvement explicitly recommends continuing melatonin through the perioperative period in cardiac surgery patients, demonstrating confidence in its cardiovascular safety profile. 1

  • A prospective trial of 500 cardiac surgery patients receiving prophylactic melatonin showed reduced postoperative delirium (8.4% vs 20.8%, p=0.001) without any reported cardiac complications. 2

  • Major cardiovascular societies (American Heart Association, American College of Cardiology, Heart Failure Society of America) do not list melatonin as contraindicated or harmful in cardiac disease patients, and specifically identify harmful medications in heart failure guidelines yet melatonin is notably absent from these warnings. 1

Potential Cardiovascular Benefits

Beyond safety, research suggests melatonin may provide cardioprotective effects:

  • Patients with coronary artery disease have significantly lower nocturnal melatonin levels (median 7.8 pg/mL vs 36.2 pg/mL in healthy controls, p<0.0001), suggesting a potential therapeutic role for supplementation. 3

  • A 30-day study in 60 patients with coronary artery disease showed that 5 mg melatonin nightly did not worsen sleep-disordered breathing patterns (a common concern in cardiac patients), with no adverse cardiac effects reported. 4

  • Melatonin demonstrates cardioprotective properties including reduction of ischemia-reperfusion injury, blood pressure reduction, and antioxidant effects that may benefit cardiac patients. 5, 6, 7

Practical Dosing for Cardiac Patients

Start with 3 mg of immediate-release melatonin taken 1.5-2 hours before bedtime. 1, 8

  • If ineffective after 1-2 weeks, increase by 3 mg increments up to a maximum of 15 mg. 1, 8
  • Lower doses (3-5 mg) are often more effective than higher doses due to receptor saturation and desensitization at doses above 10 mg. 8
  • Choose United States Pharmacopeial Convention Verified formulations to ensure reliable dosing and purity, as melatonin is regulated as a dietary supplement with variable quality control. 1, 8

Critical Drug Interactions in Cardiac Patients

Exercise caution in cardiac patients taking warfarin, as potential interactions have been reported to the World Health Organization. 2, 1

  • Monitor INR more frequently when initiating or discontinuing melatonin in anticoagulated patients. 2
  • This is particularly relevant as many cardiac patients require anticoagulation for atrial fibrillation or mechanical valves. 1

Additional Precautions

While generally safe, be aware of these considerations:

  • Patients with impaired glucose tolerance or diabetes should be monitored, as melatonin has been associated with impaired glucose tolerance in healthy individuals after acute administration. 1

  • Patients on photosensitizing medications should undergo periodic ophthalmological/dermatological monitoring. 1

  • Patients with epilepsy should use melatonin with caution based on case reports. 1

Duration of Use

  • For sleep disorders, the American Academy of Sleep Medicine recommends limiting use to 3-4 months for chronic insomnia due to limited long-term safety data beyond several months. 8
  • However, for circadian rhythm disorders, longer-term use may be appropriate with periodic reassessment every 3-6 months. 8
  • The cardiac surgery study demonstrating safety used short-term perioperative dosing, which is well-supported. 2, 1

Common Pitfalls to Avoid

  • Do not use higher doses assuming better efficacy - doses above 10 mg cause receptor desensitization and more frequent adverse effects (headache 0.74%, dizziness 0.74%) without improved benefit. 1, 8

  • Avoid unverified supplement brands - melatonin content can vary significantly from labeled amounts in non-verified formulations. 1, 8

  • Do not administer in morning or afternoon - this worsens circadian misalignment rather than helping sleep. 8

References

Guideline

Melatonin and Cardiac Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Melatonin and the cardiovascular system.

Neuro endocrinology letters, 2002

Guideline

Lower Doses of Melatonin Can Be More Effective Than Higher Doses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.